ArticleOncotarget2017
lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.
Hecun Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papercites it
ArticleOncotarget2017
Hecun Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.